These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 19432499

  • 1. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
    Binder A, Bruxelle J, Rogers P, Hans G, Bösl I, Baron R.
    Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M.
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
    Hans G, Sabatowski R, Binder A, Boesl I, Rogers P, Baron R.
    Curr Med Res Opin; 2009 May; 25(5):1295-305. PubMed ID: 19366301
    [Abstract] [Full Text] [Related]

  • 4. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M.
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
    Sabatowski R, Hans G, Tacken I, Kapanadze S, Buchheister B, Baron R.
    Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR, Tzabazis A, Likar R, Sittl R, Griessinger N.
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
    Ritchie M, Liedgens H, Nuijten M.
    Clin Drug Investig; 2010 Feb; 30(2):71-87. PubMed ID: 20067326
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia.
    Binder A, Rogers P, Hans G, Baron R.
    Pain Manag; 2016 Feb; 6(3):229-39. PubMed ID: 26821240
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials.
    Sabatowski R, Bösl I, König S, Buchheister B, Meier T, Baron R.
    Curr Med Res Opin; 2017 Mar; 33(3):595-603. PubMed ID: 28035844
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.
    Liedgens H, Hertel N, Gabriel A, Nuijten M, Dakin H, Mitchell S, Nautrup BP.
    Clin Drug Investig; 2008 Mar; 28(9):583-601. PubMed ID: 18666805
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.
    Amato F, Duse G, Consoletti L, Lo Presti C, Firetto V, Ciliberto G, Parigi LA, Palmieri V, Mazza M.
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4228-4235. PubMed ID: 29028074
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
    Kanai A, Kumaki C, Niki Y, Suzuki A, Tazawa T, Okamoto H.
    Pain Med; 2009 Sep; 10(5):902-9. PubMed ID: 19682274
    [Abstract] [Full Text] [Related]

  • 19. Topical pain management with the 5% lidocaine medicated plaster--a review.
    Mick G, Correa-Illanes G.
    Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
    [Abstract] [Full Text] [Related]

  • 20. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Cousins MJ, Pickthorn K, Huang S, Critchley L, Bell G.
    Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.